Show simple item record

dc.creatorMoslim, Maitham A.
dc.creatorJeyarajah, D. Rohan
dc.date.accessioned2022-01-26T14:35:08Z
dc.date.available2022-01-26T14:35:08Z
dc.date.issued2021
dc.identifier.urihttps://doi.org/10.21037/jgo-21-96
dc.identifier.urihttps://jgo.amegroups.com/article/view/55650/html
dc.identifier.urihttps://repository.tcu.edu/handle/116099117/49908
dc.description.abstractThe management of colorectal liver metastasis (CRLM) is complicated and benefits from a multidisciplinary team approach. Liver-directed therapy has been emerging as a modality for better progression-free control. In its early years, selective internal radiation therapy (SIRT) with yttrium-90 (Y-90) was confined as an end-of-line therapy. However, literature has supported other roles including: a first-line treatment for CRLM alone or in combination with systemic chemotherapy; an adjunct to second or third-line chemotherapy; and a salvage treatment for chemo-refractory disease. Although future liver remnant (FLR) hypertrophy may take 3-12 months, the SIRT effect on loco-regional disease control has rendered it to be a useful tool in some pathologies with certain strategic goals. This paper reviews the use of SIRT with Y-90 in a surgical treatment pathway. This includes: (I) an element of multidisciplinary treatment of low-volume CRLMs, (II) convert an R1 to R0 resection by sterilizing the margins of tumor near critical structures, and (III) radiation lobectomy to induce contralateral hypertrophy in order to aid in a safer resection. There are many opportunities to validate the role of SIRT as a first-line therapy along with surgical resection including an umbrella clinical trial design.en_US
dc.language.isoenen_US
dc.publisherAME Publishing Company
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceJournal of Gastrointestinal Oncology
dc.subjectColorectal liver metastasis (CRLM)en_US
dc.subjectliver-directed therapyen_US
dc.subjectselective internal radiation therapy (SIRT)en_US
dc.subjectyttrium-90 (Y-90)en_US
dc.subjectliver resectionen_US
dc.titleNarrative review of the role of yttrium-90 selective internal radiation therapy in the surgical management of colorectal liver metastasesen_US
dc.typeArticleen_US
dc.rights.holderJournal of Gastrointestinal Oncology
dc.rights.licenseCC BY-NC-ND 4.0
local.collegeSchool of Medicine
local.departmentSurgery
local.personsJeyarajah (SOM)


Files in this item

Thumbnail
This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by-nc-nd/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc-nd/4.0/